27301186|t|Palmitoyl Glycol Chitosan Micelles for Corneal Delivery of Cyclosporine
27301186|a|Different substitution degrees of palmitoyl glycol chitosan (PGC), prepared according to the literature, were used to obtain polymeric micelles that have been assessed in comparison with Pluronic F127 micelles as possible carriers for poorly soluble drugs, such as cyclosporine A. Both PGC and Pluronic micelles were studied for their interactions with cell culture substrates. The least substituted and most hydrophilic derivative, PGC21 (approximately 5% substitution), showed a strong association with cyclosporine, more than tripling the colloidal concentration with respect to the saturated solution. It showed a greater ability to open Caco-2 tight junctions and to enhance the permeability of Caco-2 substrates with respect to micelles based on higher palmitoyl substitution, conceivably due to the lower modification of the chitosan chains. Permeation and penetration experiments were performed with PGC21 and Pluronic micelles on a rabbit corneal epithelial cell line (RCE) and on excised pig corneas. It was found that both PGC and Pluronic micelles could increase the permeation of the fluorescent probe rhodamine B through RCE cells by more than ten-fold. In RCE and in pig cornea, the micelles improved the penetration of both rhodamine andr cyclosporine. For cyclosporine, the PGC21 micelles allowed penetration of approximately 1 Î¼g/mg cyclosporine A in corneal tissue, demonstrating a potential for use in immunosuppression therapies.
27301186	0	25	Palmitoyl Glycol Chitosan	T109	C0757133
27301186	26	34	Micelles	T109	C0025938
27301186	39	46	Corneal	T023	C0010031
27301186	47	55	Delivery	T169	C1705822
27301186	59	71	Cyclosporine	T116,T121	C0010592
27301186	82	94	substitution	T044	C0596324
27301186	106	131	palmitoyl glycol chitosan	T109	C0757133
27301186	133	136	PGC	T109	C0757133
27301186	139	147	prepared	T033	C4082130
27301186	165	175	literature	T170	C0023866
27301186	190	196	obtain	T169	C1301820
27301186	197	206	polymeric	T104,T122	C0032521
27301186	207	215	micelles	T109	C0025938
27301186	231	239	assessed	T052	C1516048
27301186	243	253	comparison	T052	C1707455
27301186	259	272	Pluronic F127	T109,T121	C0032253
27301186	273	281	micelles	T109	C0025938
27301186	294	302	carriers	T122	C0013161
27301186	314	321	soluble	T080	C1948047
27301186	322	327	drugs	T121	C0013227
27301186	337	351	cyclosporine A	T116,T121	C0010592
27301186	358	361	PGC	T109	C0757133
27301186	366	374	Pluronic	T109,T121	C0032253
27301186	375	383	micelles	T109	C0025938
27301186	407	419	interactions	T044	C0687133
27301186	425	437	cell culture	T059	C1331092
27301186	438	448	substrates	T167	C3891814
27301186	460	471	substituted	T044	C0596324
27301186	481	492	hydrophilic	T080	C0475370
27301186	493	503	derivative	T169	C1527240
27301186	505	510	PGC21	T109	C0757133
27301186	512	525	approximately	T080	C0332232
27301186	529	541	substitution	T044	C0596324
27301186	560	576	association with	T080	C0332281
27301186	577	589	cyclosporine	T116,T121	C0010592
27301186	614	623	colloidal	T122	C0009361
27301186	624	637	concentration	T081	C1446561
27301186	658	667	saturated	T070	C0522534
27301186	668	676	solution	T167	C0037633
27301186	698	705	ability	T032	C0085732
27301186	714	720	Caco-2	T025	C0282560
27301186	721	736	tight junctions	T030	C0242358
27301186	744	751	enhance	T052	C2349975
27301186	756	768	permeability	T070	C0031164
27301186	772	778	Caco-2	T025	C0282560
27301186	779	789	substrates	T167	C3891814
27301186	806	814	micelles	T109	C0025938
27301186	831	840	palmitoyl	T109	C3503116
27301186	841	853	substitution	T044	C0596324
27301186	884	896	modification	T169	C0392747
27301186	904	919	chitosan chains	T109,T121	C0162969
27301186	921	931	Permeation	T070	C0031164
27301186	936	947	penetration	T169	C0205321
27301186	948	959	experiments	T062	C0681814
27301186	965	974	performed	T169	C0884358
27301186	980	985	PGC21	T109	C0757133
27301186	990	998	Pluronic	T109,T121	C0032253
27301186	999	1007	micelles	T109	C0025938
27301186	1013	1019	rabbit	T015	C3887509
27301186	1020	1048	corneal epithelial cell line	T025	C1182610
27301186	1050	1053	RCE	T025	C1182610
27301186	1070	1073	pig	T015	C0039005
27301186	1074	1081	corneas	T023	C0010031
27301186	1106	1109	PGC	T109	C0757133
27301186	1114	1122	Pluronic	T109,T121	C0032253
27301186	1123	1131	micelles	T109	C0025938
27301186	1138	1146	increase	T169	C0442805
27301186	1151	1161	permeation	T070	C0031164
27301186	1169	1186	fluorescent probe	T130	C0016321
27301186	1187	1198	rhodamine B	T109,T130	C0073194
27301186	1207	1216	RCE cells	T025	C1182610
27301186	1243	1246	RCE	T025	C1182610
27301186	1254	1257	pig	T015	C0039005
27301186	1258	1264	cornea	T023	C0010031
27301186	1270	1278	micelles	T109	C0025938
27301186	1279	1287	improved	T033	C0184511
27301186	1292	1303	penetration	T169	C0205321
27301186	1312	1321	rhodamine	T109,T130	C0035483
27301186	1327	1339	cyclosporine	T116,T121	C0010592
27301186	1345	1357	cyclosporine	T116,T121	C0010592
27301186	1363	1368	PGC21	T109	C0757133
27301186	1369	1377	micelles	T109	C0025938
27301186	1386	1397	penetration	T169	C0205321
27301186	1401	1414	approximately	T080	C0332232
27301186	1423	1437	cyclosporine A	T116,T121	C0010592
27301186	1441	1448	corneal	T023	C0010031
27301186	1449	1455	tissue	T024	C0040300
27301186	1473	1482	potential	T080	C3245505
27301186	1494	1521	immunosuppression therapies	T061	C0021079